A Study of PEGASYS (Peginterferon Alfa-2a) Plus Ribavirin in Patients With Chronic Hepatitis C (CHC), Genotype 2 or 3

NCT01258101 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

395

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: peginterferon alfa-2a [Pegasys]
DRUG: peginterferon alfa-2a [Pegasys]
DRUG: ribavirin
DRUG: ribavirin

Sponsor

Hoffmann-La Roche